Selected Publication:
SHR
Neuro
Cancer
Cardio
Lipid
Metab
Microb
Jasser-Nitsche, H; Bechtold-Dalla Pozza, S; Binder, E; Bollow, E; Heidtmann, B; Lee-Barkley, YH; Raile, K; de Sousa, G; Schramm, U; Holl, RW.
Comorbidity of inflammatory bowel disease in children and adolescents with type 1 diabetes.
Acta Paediatr. 2021; 110(4):1353-1358
Doi: 10.1111/apa.15643
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
-
Jasser-Nitsche Hildegard
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
-
To determine the prevalence of inflammatory bowel disease (IBD) in patients with type 1 diabetes (T1D) and to characterise patients with both diseases.
Data of 65.147 patients with T1D ≤18 years of 379 centres in Germany and Austria participating in the DPV initiative were analysed. A total of 63 children had comorbid IBD; IBD prevalence was 0.1%. Regression models were used to analyse differences in metabolic control, acute complications and steroid intake.
Mean BMI-SDS in patients with T1D and IBD was lower (-0.15 ± 0.11) compared to patients with T1D only (0.27 ± 0.00, p < .001). Patients with T1D and IBD had a significantly higher use of steroids (22% ± 0.05% vs. 1% ± 0.00, p < .001) and a significantly higher rate of severe hypoglycaemic events per patient year (0.33 ± 0.07 vs. 0.16 ± 0.00, p = .001). No differences were found in HbA1c levels, insulin dose and occurrence of DKA.
Although children and adolescents with T1D and IBD take steroids more often, they suffer from severe hypoglycaemia more frequently and have a lower BMI-SDS. These findings might be explained by chronic intestinal inflammation leading to malabsorption, malnutrition and increased severe hypoglycaemia.
©2020 The Authors. Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.
- Find related publications in this database (Keywords)
-
children
-
hypoglycaemia
-
inflammatory bowel disease
-
prevalence
-
type 1 diabetes